1. Malaysia Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
TMC Life Sciences Berhad

TMC Life Sciences Berhad

0101.KL
TMC Life Sciences BerhadMY flagMalaysian Stock Exchange
0.46
MYR
+0.01
- -
792.56MMarket Cap
TMC Life Sciences Berhad
0101.KL
(Malaysian Stock Exchange)

Recent

price

0.46

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2011
2012
2013
2014
2015
2016
2017
2018
2019
2021
2022
2023
2024
2025
TTM
FRC
0.07
0.07
0.13
0.09
0.09
0.11
0.1
0.08
0.09
0.1
0.11
0.12
0.14
0.18
0.2
0.2
0.22
Revenue per Share
0.01
-0.01
-0.06
-0.01
0.01
0.01
0.01
0.01
0.02
0.02
0.01
0.01
0.02
0.02
0.02
- -
0.01
Basic EPS, GAAP
-0.08
-0.05
- -
-0.01
0.01
0.01
- -
- -
- -
-0.01
-0.02
-0.05
-0.02
0.01
0.03
-0.01
0.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.01
0.02
- -
Dividend per Share
0.16
0.12
0.08
0.09
0.09
0.09
0.12
0.11
0.38
0.4
0.44
0.45
0.47
0.49
0.51
0.49
0.5
Book Value per Share
0.18
0.13
0.11
0.17
0.16
0.17
0.31
0.29
0.3
0.31
0.33
0.34
0.36
0.38
0.39
0.37
0.38
Tangible Book Value per Share
562
655
602
690
802
802
985
1,701
1,735
1,736
1,738
1,742
1,742
1,742
1,742
1,742
1,742
Basic Weighted Avg Shares
39
47
81
59
71
86
103
128
152
169
195
201
244
311
346
346
387
Sales/Revenue/Turnover
11.75
-14.73
-15.62
-5.01
2.5
6.76
4.05
9.45
12.37
14.42
15.37
12.37
12.34
13.79
15.37
2.21
5.76
Operating Margin (%)
2
8
12
8
7
8
8
9
11
13
11
13
16
26
28
34
37
Depreciation Expense
4
-9
-35
-6
11
6
10
15
26
28
21
20
41
39
41
4
15
Net Income, GAAP
16.68
- -
- -
- -
- -
4.2
- -
27.41
4.07
16.02
45.17
26.81
- -
3.99
22.75
49.01
30.19
Effective Tax Rate (%)
9.21
-18.65
-43.44
-10.84
15.64
7.47
9.62
11.66
17.16
16.44
10.73
10.08
16.98
12.6
11.73
1.04
3.92
Profit Margin (%)
32
-4
-19
10
26
34
191
189
206
204
167
110
114
153
164
92
88
Working Capital
28
41
39
7
2
2
2
2
2
2
2
172
200
201
180
143
109
LT Debt
114
104
67
120
131
135
302
634
714
740
762
790
827
862
888
853
863
Total Equity
3.34
- -
- -
- -
- -
4.34
- -
1.88
2.68
2.84
2.21
2.12
- -
3.91
3.79
0.37
1.51
Return on Invested Capital (%)
4.75
- -
- -
- -
- -
8.84
- -
9.57
6.1
4.1
2.89
2.39
- -
4.56
4.47
0.79
2.02
Return on Capital (%)
5.08
-10.12
-55.15
-12.32
17.19
8.96
10.15
9.65
6.11
4.1
2.89
2.62
5.14
4.66
4.65
0.41
1.77
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
44
47
47
LT Borrowings
130
119
108
LT Finance Leases
2
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,742
1,742
1,742
Market Capitalization
740
784
836

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
203
202
195
Cash, Cash Equivalents & STI
111
113
118
Accounts Receivable, Net
65
64
58
Inventories
17
18
19
Total Current Liabilities
110
108
107
Payables & Accruals
- -
- -
- -
ST Debt
44
47
47
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
26.39%
2.33%
-3.94%
Free Cash Flow
-79.89%
-14.37%
-140.32%
Net Income, GAAP
16.9%
1.69%
-91.13%
Sales/Revenue/Turnover
15.17%
12.62%
-0.25%
Total Cash Common Dividend
44.57%
83.33%
163.99%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
92
94
86
74
346
2025
82
80
90
93
346
2026
100
103
90
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
0.01
- -
0.02
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.01
2025
- -
- -
- -
- -
0.02
2026
- -
- -
- -
- -
- -
Similar Companies
HYUGA PRIMARY CARE Co.,Ltd. (7133.T)
Town Health International Medical Group Limited (3886.HK)
The Amacore Group, Inc. (ACGI)
Mediclinic International plc (MEI.JO)
JRSIS Health Care Corporation (JRSS)
Nexteligent Holdings, Inc. (NXGT)
Business
TMC Life Sciences Berhad (TMCLIFE:KLS) operates as an investment holding company that provides integrated healthcare services in Malaysia, with a focus on multi-disciplinary tertiary care and fertility treatments. The company offers comprehensive medical services through its Thomson Hospital Kota Damansara (THKD), including specialties such as obstetrics and gynaecology, cancer care, cardiology, orthopaedics, ENT, gastroenterology, urology, anesthesiology, dermatology, colorectal, internal medicine, and respiratory medicine; fertility services via TMC Fertility encompassing in-vitro fertilisation, preimplantation genetic testing, fertility preservation, laparoscopic surgery, surgical sperm retrieval, and donation programmes; fertility consultancy, laboratory, and embryology services; women's clinics; pharmacy services and products; traditional and complementary medicine; management support services; healthcare programme development, marketing, and management; and research and development activities, as well as property investment. Founded in 1994 and headquartered in Petaling Jaya, Selangor, it primarily serves patients in Malaysia with growing emphasis on medical tourism from Southeast Asia. TMC Life Sciences Berhad is a subsidiary of Sasteria (M) Pte. Ltd. and operates mainly through segments including Thomson Hospitals Sdn. Bhd. and IVF Technologies Sdn. Bhd. In recent developments, the company established a strategic partnership with OncoCare Medical Malaysia Sdn. Bhd. in September 2024 to enhance oncology services at THKD, contributing to revenue growth and improved profit before taxation in quarters through March 2025; it reported strong financial performance for FY2023/24 with revenue of RM364.14 million and cash balances of RM188.6 million, alongside optimism for FY2024/25 driven by expanded capacity, fertility business resurgence, and medical tourism; additionally, it declared dividends including a final single tier dividend of 0.4898 sen and a special dividend for the period ended March 2025, while pursuing sustainability goals like Net Zero by 2050.